Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
12.24
+0.06 (0.49%)
Mar 6, 2025, 4:00 PM EST - Market closed
Dyne Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '25 Mar 6, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 1,385 | 2,398 | 816 | 604 | 606 | 954 | |
| Market Cap Growth | 193.72% | 193.72% | 35.12% | -0.31% | -36.50% | - | |
| Enterprise Value | 766 | 1,699 | 687 | 387 | 233 | 585 | |
| Last Close Price | 12.18 | 23.56 | 13.30 | 11.59 | 11.89 | 21.00 | |
| PB Ratio | 1.98 | 3.81 | 8.94 | 2.39 | 1.65 | 2.79 | |
| P/TBV Ratio | 3.81 | 3.81 | 8.94 | 2.39 | 1.65 | 2.79 | |
| Debt / Equity Ratio | 0.04 | 0.04 | 0.30 | 0.12 | 0.09 | - | |
| Quick Ratio | 15.20 | 15.20 | 2.41 | 9.11 | 13.11 | 31.49 | |
| Current Ratio | 15.60 | 15.60 | 2.53 | 9.46 | 13.31 | 31.83 | |
| Return on Equity (ROE) | -88.03% | -88.03% | -137.31% | -54.18% | -42.02% | -33.35% | |
| Return on Assets (ROA) | -50.20% | -50.20% | -64.21% | -29.19% | -24.07% | -19.83% | |
| Return on Capital (ROIC) | -55.64% | -55.64% | -75.38% | -31.26% | -25.23% | -20.57% | |
| Earnings Yield | -22.92% | -13.24% | -28.90% | -27.83% | -24.63% | -6.23% | |
| FCF Yield | -21.29% | -12.29% | -23.14% | -25.94% | -20.33% | -4.99% | |
| Buyback Yield / Dilution | -57.74% | -57.74% | -14.83% | -2.12% | -253.54% | -489.30% | |
| Total Shareholder Return | -57.74% | -57.74% | -14.83% | -2.12% | -253.54% | -489.30% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.